Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia.

Bartzokis G, Lu PH, Stewart SB, Oluwadara B, Lucas AJ, Pantages J, Pratt E, Sherin JE, Altshuler LL, Mintz J, Gitlin MJ, Subotnik KL, Nuechterlein KH.

Schizophr Res. 2009 Sep;113(2-3):322-31. doi: 10.1016/j.schres.2009.06.014.

2.

Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia.

Bartzokis G, Lu PH, Nuechterlein KH, Gitlin M, Doi C, Edwards N, Lieu C, Altshuler LL, Mintz J.

Schizophr Res. 2007 Jul;93(1-3):13-22. Erratum in: Schizophr Res. 2008 Feb;99(1-3):379.

3.

Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.

Bartzokis G, Lu PH, Raven EP, Amar CP, Detore NR, Couvrette AJ, Mintz J, Ventura J, Casaus LR, Luo JS, Subotnik KL, Nuechterlein KH.

Schizophr Res. 2012 Sep;140(1-3):122-8. doi: 10.1016/j.schres.2012.06.036.

4.

Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory.

Bartzokis G, Lu PH, Amar CP, Raven EP, Detore NR, Altshuler LL, Mintz J, Ventura J, Casaus LR, Luo JS, Subotnik KL, Nuechterlein KH.

Schizophr Res. 2011 Oct;132(1):35-41. doi: 10.1016/j.schres.2011.06.029.

5.

Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.

McClure RK, Carew K, Greeter S, Maushauer E, Steen G, Weinberger DR.

Schizophr Res. 2008 Jan;98(1-3):29-39.

PMID:
17976957
6.

Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.

Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, Fearon P, McGuire PK, Mallett RM, Jones PB, Leff J, Murray RM.

Neuropsychopharmacology. 2005 Apr;30(4):765-74.

7.

Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study.

Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J.

Biol Psychiatry. 2003 Mar 1;53(5):412-21.

PMID:
12614994
8.

Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.

Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, de Kroon B, Grobbee DE, Hulshoff Pol HE, Kahn RS.

J Clin Psychopharmacol. 2011 Apr;31(2):146-53. doi: 10.1097/JCP.0b013e31820e3f58.

PMID:
21346618
9.

Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.

Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T.

Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13432-7.

10.

A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.

Lesh TA, Tanase C, Geib BR, Niendam TA, Yoon JH, Minzenberg MJ, Ragland JD, Solomon M, Carter CS.

JAMA Psychiatry. 2015 Mar;72(3):226-34. doi: 10.1001/jamapsychiatry.2014.2178.

11.

Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.

Tomelleri L, Jogia J, Perlini C, Bellani M, Ferro A, Rambaldelli G, Tansella M, Frangou S, Brambilla P; Neuroimaging Network of the ECNP networks initiative..

Eur Neuropsychopharmacol. 2009 Dec;19(12):835-40. doi: 10.1016/j.euroneuro.2009.07.007.

PMID:
19717283
12.

No amygdala attenuation in schizophrenic patients treated with atypical antipsychotics.

Sachs G, Moser E, Katschnig H, Gur RC, Gur RE, Erfurth A.

Psychiatry Res. 2012 May 31;202(2):168-71. doi: 10.1016/j.pscychresns.2012.02.009.

PMID:
22703618
13.

Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.

Schlagenhauf F, Dinges M, Beck A, Wüstenberg T, Friedel E, Dembler T, Sarkar R, Wrase J, Gallinat J, Juckel G, Heinz A.

Schizophr Res. 2010 May;118(1-3):189-200. doi: 10.1016/j.schres.2010.01.022.

PMID:
20189356
14.

Insular cortex abnormalities in schizophrenia: Relationship to symptoms and typical neuroleptic exposure.

Pressler M, Nopoulos P, Ho BC, Andreasen NC.

Biol Psychiatry. 2005 Feb 15;57(4):394-8.

PMID:
15705355
15.

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V.

Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.

16.

The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.

Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rössler A, Borgwardt SJ.

Curr Pharm Des. 2009;15(22):2535-49. Review.

PMID:
19689326
17.

Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.

Ahmed M, Cannon DM, Scanlon C, Holleran L, Schmidt H, McFarland J, Langan C, McCarthy P, Barker GJ, Hallahan B, McDonald C.

Neuropsychopharmacology. 2015 Sep;40(10):2409-17. doi: 10.1038/npp.2015.90.

18.

Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients.

Molina V, Papiol S, Sanz J, Rosa A, Arias B, Fatjó-Vilas M, Calama J, Hernández AI, Bécker J, Fañanás L.

Neuroimage. 2011 May 1;56(1):45-51. doi: 10.1016/j.neuroimage.2011.01.076.

PMID:
21296169
19.

Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.

Li M, Chen Z, Deng W, He Z, Wang Q, Jiang L, Ma X, Wang Y, Chua SE, Cheung C, McAlonan GM, Sham PC, Collier DA, Gong Q, Li T.

Psychol Med. 2012 Jul;42(7):1475-83. doi: 10.1017/S0033291711002157.

PMID:
22030695
20.

Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia.

Nesvåg R, Frigessi A, Jönsson EG, Agartz I.

Schizophr Res. 2007 Feb;90(1-3):52-61.

PMID:
17218084
Items per page

Supplemental Content

Support Center